Medtronic plc.

Open: 81.52 Close: 82.19 Change: 0.67

The 7 top things that an AI found about Medtronic plc. Company Inc... they will surprise you

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, report, MDT, share, quarterly, company, earnings, and the most common words in the summary are: medtronic, stock, market, news, mdt, plc, earnings, . One of the sentences in the summary was: The return of non-urgent surgery volumes boosted demand for its medical …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Ireland-based Medtronic (NYSE: MDT) is a major player in the medical device industry. The return of non-urgent surgery volumes boosted demand for its medical devices, sending its shares up 3%. The company recently announced its quarterly earnings results on Thursday, May 25th.

Today's News

Medtronic PLC (MDT) stock has risen 1.62% while the S&P 500 has risen 0.85% as of 3:14 PM on Friday, Aug. 25. Shares of Medtronics PLC MDT rallied 1.39% to $82.19 Friday. Medtronic raises profit forecast as surgeries return to pre-pandemic levels. The return of non-urgent surgery volumes boosted demand for its medical devices, sending its shares up 3%. Excluding items, Medtronics reported quarterly profit of $1.20 per share that beat estimates of $ 1.11. Ireland-based Medtronic (NYSE: MDT) is a major player in the medical device industry. The company recently announced its quarterly earnings results on Thursday, May 25th. Investors considering Medtronic should take note of its current market performance and monitor future updates from the company to make informed decisions about their investments. Investors considering investing in the medical device company should monitor its performance. Medtronic PLC (MDT) on Tuesday reported fiscal first-quarter profit of $791 million. Company expects full-year earnings in the range of $5.08 to $5.16 per share. Medtronic plans to report its FY24 second, third, and fourth quarter results on November 21, 2023 ; February 20, 2024 ; and May 23, 2024. The charge relates to an income tax reserve adjustment. Medtronic has received CE Mark approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) Device automatically adjusts therapy based on signals from the spinal cord. Medtronic reported Q1 worldwide revenue of $7.702 billion, an increase of 4.5% as reported and 6.0% on an organic basis. The Symplicity Spyral™ renal denervation (RDN) system uses a minimally invasive procedure that delivers radiofrequency (RF) energy. Medtronic (MDT) reported adjusted earnings per share (EPS) of $1.20 for first-quarter fiscal 2024 compared with the year-ago quarters EPS of $ 1.13. The board of directors of Medtronic plc (NYSE: MDT ) on Thursday, August 17, 2023, approved an increase in the companys cash dividend. Medtronic ( NYSE:MDT – Get Free Report ) last issued its quarterly earnings results on Tuesday, August 22nd. The business also recently declared a quarterly dividend, which will be paid on October 13th. Medtronic PLC (MDT) on Tuesday reported fiscal first-quarter profit of $791 million. Medtronics expects full-year earnings in the range of $5.08 to $5.16 per share. MedTronic trades on the NYSE under the ticker. Medtronic plans to report its FY24 second, third, and fourth quarter results on November 21, 2023 ; February 20, 2024 ; and May 23, 2024. The first quarter financial schedules and non-GAAP reconciliations can be viewed by clicking on the Investor Events link at investorrelations.medtronic. Medtronic releases first quarter results for FY24. FDA review panel voted against recommending approval of Symplicity Spyral renal denervation therapy for hypertension. Medtronic has an analyst consensus of Moderate Buy, with a price target consensus of $98.13, implying a 17.21% upside from current levels. Medtronics has an analysts rating of 1(buy) to 5(sell) on a scale from 1-buy-to-1(buy-sell) to 1(sell). The company reported a quarterly revenue of $8.54 billion. Medtronic received CE Mark approval for Inceptiv™ spinal cord stimulator.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, report, MDT, share, quarterly, company, earnings, and the most common words in the summary are: medtronic, stock, market, news, mdt, plc, earnings, . One of the sentences in the summary was: The return of non-urgent surgery volumes boosted demand for its medical devices, sending its shares up 3%. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #news #mdt #plc #earnings.